SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
MEDTRONIC, INC.
(Exact Name of Registrant as Specified in its Charter)
Minnesota 41--0793183
(State of Incorporation) (I.R.S. Employer Identification Number)
7000 Central Avenue N.E.
Minneapolis, Minnesota 55432
(Address of Principal Executive Office and Zip Code)
MEDTRONIC, INC.
1994 STOCK AWARD PLAN
(Full Title of the Plan)
Carol E. Malkinson
Senior Legal Counsel and Assistant Secretary
Medtronic, Inc.
7000 Central Avenue N.E.
Minneapolis, Minnesota 55432
(763) 514-4000
(Name, Address and Telephone Number, Including Area Code, of Agent for Service)
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
----------------------- ------------------- ------------------- --------------------- ------------------
Proposed Maximum Proposed Maximum
Title of Securities Amount to be Offering Price Aggregate Offering Amount of
to be Registered Registered (1) Per Share (2) Price (2) Registration Fee
----------------------- ------------------- ------------------- --------------------- ------------------
<S> <C> <C> <C> <C>
Common stock, $0.10
par value (3) 8,000,000 shares $49.31 $394,480,000 $104,143
----------------------- ------------------- ------------------- --------------------- ------------------
</TABLE>
(1) In addition, pursuant to Rule 416 under the Securities Act of 1933, this
Registration Statement also covers an indeterminate amount of interests to be
offered or sold pursuant to the employee benefit plan described herein and any
additional securities which may become issuable pursuant to anti-dilution
provisions of the plan.
(2) Estimated pursuant to Rule 457(h) solely for the purpose of calculating the
registration fee and based upon the average of the high and low prices of the
Registrant's Common Stock on August 22, 2000.
(3) Each share of Common Stock includes a Preferred Stock Purchase Right
pursuant to the Registrant's Shareholder Rights Plan.
<PAGE>
The contents of the Registrant's Form S-8 Registration Statement,
Registration No. 33-55329 dated September 1, 1994, relating to the 1994 Stock
Award Plan, are incorporated herein by reference.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
4.1 Medtronic Restated Articles of Incorporation, as amended to
date.(a)
4.2 Medtronic Bylaws, as amended to date.(b)
4.3 Form of Rights Agreement dated as of June 27, 1991 between
Medtronic and Norwest Bank Minnesota, National Association,
including as Exhibit A thereto the form of Preferred Stock
Purchase Right Certificate.(c)
5. Opinion of counsel as to the legality of securities being
registered.
23.1 Consent of counsel (contained in Exhibit 5).
23.2 Consent of PricewaterhouseCoopers LLP
24. Power of Attorney
99. Medtronic, Inc. 1994 Stock Award Plan (Amended and Restated as of
April 30, 2000).(d)
------------------
(a) Incorporated by reference to Exhibit 3.1 in Medtronic's Quarterly Report
on Form 10-Q for the quarter ended October 29, 1999, filed with the
Commission on December 10, 1999.
(b) Incorporated by reference to Exhibit 3.2 in Medtronic's Annual Report on
Form 10-K for the fiscal year ended April 30, 1996, filed with the
Commission on July 24, 1996.
(c) Incorporated by reference to Exhibit 4 in Medtronic's Annual Report on
Form 10-K for the fiscal year ended April 30, 1997, filed with the
Commission on July 23, 1997.
(d) Incorporated by reference to Exhibit 10.1 in Medtronic's Annual Report on
Form 10-K for the fiscal year ended April 30, 2000, filed with the
Commission on July 21, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Minneapolis and State of Minnesota, on August 29,
2000.
MEDTRONIC, INC.
By: /s/ WILLIAM W. GEORGE
-------------------------------------------
William W. George
Chairman and
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in the
capacities and on the dates indicated.
Dated: August 29, 2000 By: /s/ WILLIAM W. GEORGE
-------------------------------------------
William W. George
Chairman and
Chief Executive Officer
Dated: August 29, 2000 By: /s/ ROBERT L. RYAN
-------------------------------------------
Robert L. Ryan
Senior Vice President and
Chief Financial Officer
(Principal Financial and Accounting Officer)
Michael R. Bonsignore*
William R. Brody, M.D., Ph.D.*
Paul W. Chellgren*
Arthur D. Collins, Jr.*
William W. George* Directors
Antonio M. Gotto, Jr., M.D.*
Bernadine P. Healy, M.D.*
Glen D. Nelson, M.D.*
Jean-Pierre Rosso*
Jack W. Schuler*
Gordon M. Sprenger*
*David J. Scott, by signing his name hereto, does hereby sign this
document on behalf of each of the above named directors of the registrant
pursuant to powers of attorney duly executed by such persons.
Dated: August 29, 2000 By: /s/ DAVID J. SCOTT
-------------------------------------------
David J. Scott
Attorney-In-Fact
<PAGE>
MEDTRONIC, INC.
Form S-8 Registration Statement
EXHIBIT INDEX
Exhibit
Number Exhibit Description
------ -------------------
4.1 Medtronic Restated Articles of Incorporation, as amended to
date.(a)
4.2 Medtronic Bylaws, as amended to date.(b)
4.3 Form of Rights Agreement dated as of June 27, 1991 between
Medtronic and Norwest Bank Minnesota, National Association,
including as Exhibit A thereto the form of Preferred Stock
Purchase Right Certificate.(c)
5. Opinion of counsel as to the legality of securities being
registered.
23.1 Consent of counsel (contained in Exhibit 5).
23.2 Consent of PricewaterhouseCoopers LLP
24. Power of Attorney
99. Medtronic, Inc. 1994 Stock Award Plan (Amended and Restated as of
April 30, 2000).(d)
(a) Incorporated by reference to Exhibit 3.1 in Medtronic's Quarterly Report
on Form 10-Q for the quarter ended October 29, 1999, filed with the
Commission on December 10, 1999.
(b) Incorporated by reference to Exhibit 3.2 in Medtronic's Annual Report on
Form 10-K for the fiscal year ended April 30, 1996, filed with the
Commission on July 24, 1996.
(c) Incorporated by reference to Exhibit 4 in Medtronic's Annual Report on
Form 10-K for the fiscal year ended April 30, 1997, filed with the
Commission on July 23, 1997.
(d) Incorporated by reference to Exhibit 10.1 in Medtronic's Annual Report on
Form 10-K for the fiscal year ended April 30, 2000, filed with the
Commission on July 21, 2000.
